Public trial registry of the CCC-Munich

Trial A536-05

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
A536-05
World
Full title
:

An Open-Label Extension Study to Evaluate the Long-Term Effect of ACE-536 for the Treatment of Anemia in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Previosly Enrolled in Study A536-03
Z-Nummer: 304

World
NCT number
:
World
Responsible organization
:
3. Med 3. Med Ismaninger Str. 22 81675 München Germany Tum
Indications
Classification Code Description
- D46.9 Myelodysplastisches Syndrom, nicht näher bezeichnet
Trial design
World
Phase
:
II
Status
World
Status
:
Recruitment active
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo

Participants
Function Prename Surname Organization
World Responsible contact Katharina Götze Keine Organisationseinheit angegeben Magnifier